[Edinburgh, UK] – Caritas Science Solutions, a boutique Contract Research Organisation (CRO) specialising in neurology, has announced the launch of a new oncology arm. The company will now offer clinical trial services to the oncology community, in addition to their existing services in neurology.
The expansion into oncology comes after careful consideration and planning. With this new arm, Caritas Science Solutions aims to contribute to the development of new treatments and therapies for cancer patients, while leveraging their expertise in conducting clinical trials.
“I am so proud of how the company has evolved over the last 6 years and really excited for this next phase of our expansion. This feels like the natural and logical next step in our growth, given that we have so much oncology expertise already within the organisation and our clients regularly ask us for this. We’re excited to embrace our market leading position in these keys areas of unmet need so as to support the development of safe and efficacious treatments for the patients that need them said Leigh Fell, CEO of Caritas Science Solutions. “We believe that our expertise in clinical trials and our dedication to patient care will allow us to make a meaningful impact in the field of oncology.”
Caritas Science Solutions is a boutique CRO with a proven track record of successful clinical trials in neurology, and is committed to maintaining the same level of excellence in their new oncology arm. The company will work closely with cancer researchers, healthcare providers, and patients to identify new therapies and treatments that can improve the lives of those affected by cancer.
The launch of the oncology arm is a significant milestone for Caritas Science Solutions, and represents the company’s commitment to expanding their services and making a positive impact in the medical community.
For more information, please visit www.caritasscience.co.uk
